rotigotine transdermal Neupro
Selected indexed studies
- ** (, 2016) [PMID:28121102]
- Rotigotine. (, 2012) [PMID:31643273]
- Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. (J Clin Sleep Med, 2025) [PMID:39324694]
_Worker-drafted node — pending editorial review._
Connections
rotigotine transdermal Neupro is a side effect of
Sources
- Rotigotine Transdermal Patch: A Review in Parkinson's Disease. (2019) pubmed
- Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease. (2011) pubmed
- Rotigotine. (2012) pubmed
- PMID:28121102 (2016) pubmed
- Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. (2025) pubmed
- Contact leukoderma induced by rotigotine transdermal patch (Neupro®). (2019) pubmed
- Parkinson Disease Agents. (2012) pubmed
- Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome. (2016) pubmed
- Transdermal rotigotine (Neupro) for Parkinson's disease. (2007) pubmed
- In brief: transdermal rotigotine (Neupro). (2012) pubmed